# Moyamoya Disease and Syndrome in Adults: A Report of Four Cases

**Authors:** Ghizlane Es-sayeh, Siham Bouchal, Y Lamrani, Mustapha Maaroufi, Mohammed Faouzi Belahsen

PMC · DOI: 10.7759/cureus.85357 · Cureus · 2025-06-04

## TL;DR

This paper reports four adult cases of Moyamoya disease or syndrome, highlighting their clinical features, diagnosis, and treatment approaches.

## Contribution

The novelty lies in presenting four adult cases with varied clinical presentations and etiologies, contributing to understanding of this rare condition.

## Key findings

- Three patients presented with ischemic stroke, while one had multiple cerebrovascular events.
- Diagnosis was confirmed using CT angiography and cerebral digital subtraction angiography.
- Medical treatment with calcium channel blockers and antiplatelet agents was used without revascularization.

## Abstract

Moyamoya disease and syndrome is a rare angiogenic disorder characterized by progressive narrowing of the distal internal carotid artery and proximal segments of the middle and anterior cerebral arteries, leading to the formation of replacement vessels to compensate for reduced cerebral perfusion downstream of the stenosis. Its etiology remains poorly understood, and its most serious consequences are ischemic or hemorrhagic stroke. It may be primary or secondary. We present four cases of Moyamoya disease and syndrome, including three women and one man, with ages of 42, 44, 46, and 45 years, respectively. Three patients presented with ischemic stroke, and one patient experienced multiple ischemic and hemorrhagic cerebrovascular events. All four had undergone emergency cerebral CT and/or MRI, but the diagnosis was made by CT angiography and cerebral digital subtraction angiography. All four patients received medical treatment with calcium channel blockers and antiplatelet agents, with rehabilitation, and none underwent revascularization. The etiological investigation revealed Sjögren’s syndrome in one patient, hyperthyroidism in another, and no abnormalities in the remaining cases. Through these four observations, we discuss the clinical presentations, diagnosis, and therapeutic features of this rare condition.

## Linked entities

- **Diseases:** Moyamoya disease (MONDO:0016820), ischemic stroke (MONDO:1060198), hemorrhagic stroke (MONDO:1060199), hyperthyroidism (MONDO:0004425)

## Full-text entities

- **Diseases:** hemorrhagic cerebrovascular (MESH:D006470), ischemic stroke (MESH:D002544), stenosis (MESH:D003251), hyperthyroidism (MESH:D006980), ischemic (MESH:D002545), Moyamoya Disease and Syndrome (OMIM:300845), angiogenic disorder (MESH:D009358), hemorrhagic stroke (MESH:D000083302), Sjogren's syndrome (MESH:D012859)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12227196/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12227196/full.md

## References

20 references — full list in the complete paper: https://tomesphere.com/paper/PMC12227196/full.md

---
Source: https://tomesphere.com/paper/PMC12227196